Cargando…
Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA
OBJECTIVE: A widely recognized metabolic side effect of glucocorticoid (GC) therapy is steroid-induced diabetes mellitus (DM). However, studies on the molecular basis of GC-induced pancreatic beta cell dysfunction in human beta cells are lacking. The significance of non-coding RNAs in various cellul...
Autores principales: | Esguerra, Jonathan L.S., Ofori, Jones K., Nagao, Mototsugu, Shuto, Yuki, Karagiannopoulos, Alexandros, Fadista, Joao, Sugihara, Hitoshi, Groop, Leif, Eliasson, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976904/ https://www.ncbi.nlm.nih.gov/pubmed/32029226 http://dx.doi.org/10.1016/j.molmet.2019.12.012 |
Ejemplares similares
-
Glucocorticoid-mediated induction of ZBTB16 affects insulin secretion in human islets and EndoC-βH1 β-cells
por: Karagiannopoulos, Alexandros, et al.
Publicado: (2023) -
Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells
por: Nagao, Mototsugu, et al.
Publicado: (2020) -
Human pancreatic islet miRNA-mRNA networks of altered miRNAs due to glycemic status
por: Karagiannopoulos, Alexandros, et al.
Publicado: (2022) -
The highly expressed calcium‐insensitive synaptotagmin‐11 and synaptotagmin‐13 modulate insulin secretion
por: Ofori, Jones K., et al.
Publicado: (2022) -
Comparative analysis of lincRNA in insect species
por: Lopez-Ezquerra, Alberto, et al.
Publicado: (2017)